Trial
NCT01541397
Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
BioMarin Pharmaceutical
Condition
Hyperphenylalaninemia
Intervention
Sapropterin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-07